TrialBMC infectious diseases2010

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.

Sukanta Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.